Ameriprise’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.3K | Sell |
30,030
-8,774
| -23% | -$23.2K | ﹤0.01% | 3867 |
|
|
2025
Q1 | $117K | Buy |
38,804
+23,790
| +158% | +$71.6K | ﹤0.01% | 3830 |
|
|
2024
Q4 | $38.4K | Buy |
+15,014
| New | +$38.4K | ﹤0.01% | 3994 |
|
|
2024
Q3 | – | Sell |
-11,155
| Closed | -$70.5K | – | 3960 |
|
|
2024
Q2 | $70.5K | Sell |
11,155
-3,860
| -26% | -$24.4K | ﹤0.01% | 3802 |
|
|
2024
Q1 | $80.6K | Sell |
15,015
-6,085
| -29% | -$32.7K | ﹤0.01% | 3792 |
|
|
2023
Q4 | $106K | Buy |
+21,100
| New | +$106K | ﹤0.01% | 3808 |
|
|
2023
Q3 | – | Sell |
-22,400
| Closed | -$62.3K | – | 3919 |
|
|
2023
Q2 | $62.3K | Buy |
+22,400
| New | +$62.3K | ﹤0.01% | 3852 |
|
|
2023
Q1 | – | Sell |
-67,995
| Closed | -$345K | – | 3980 |
|
|
2022
Q4 | $345K | Buy |
+67,995
| New | +$345K | ﹤0.01% | 3535 |
|
|
2021
Q4 | – | Sell |
-27,615
| Closed | -$269K | – | 4001 |
|
|
2021
Q3 | $269K | Sell |
27,615
-520
| -2% | -$5.07K | ﹤0.01% | 3616 |
|
|
2021
Q2 | $402K | Buy |
28,135
+35
| +0.1% | +$500 | ﹤0.01% | 3532 |
|
|
2021
Q1 | $667K | Buy |
28,100
+490
| +2% | +$11.6K | ﹤0.01% | 3299 |
|
|
2020
Q4 | $368K | Buy |
+27,610
| New | +$368K | ﹤0.01% | 3433 |
|
|
2018
Q4 | – | Sell |
-11,850
| Closed | -$44K | – | 3693 |
|
|
2018
Q3 | $44K | Buy |
11,850
+240
| +2% | +$891 | ﹤0.01% | 3662 |
|
|
2018
Q2 | $35K | Buy |
+11,610
| New | +$35K | ﹤0.01% | 3597 |
|